Kymab
Trending Articles
Related Content
Pharmaceutical
Kymab announce promising new antibody for autoimmune treatment
Kymab, an emerging biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs, announce KY1005, its novel human antibody therapeutic, has successfully completed dosing of the 24th subject in its first clinical study